Company Overview and News

 
Andromeda Metals targets next steps for gold, copper and graphite exploration

2017-10-24 proactiveinvestors.com.au
Andromeda Metals Ltd (ASX:ADN) has a portfolio of projects in Australia, and most recently took full-control of the Rover Copper Gold Project in the Northern Territory.
Upvote Downvote

 
Emmerson Resources talks Government support of Tennant Creek in Proactive Q&A Sessions™

2017-05-04 proactiveinvestors.com.au
Emmerson Resources (ASX:ERM) maintains a strategy of discovering a new generation of large, high grade gold deposits in Tennant Creek.
Upvote Downvote

 
Andromeda Metals is the new Adelaide Resources

2017-01-03 proactiveinvestors.com.au
The company’s current focus is the wholly owned, 2,807 square kilometre Eyre Peninsula gold project in South Australia.
Upvote Downvote

 
Adelaide Resources Ltd to begin drilling for gold at Eyre Peninsula

2016-09-21 proactiveinvestors.com.au
Adelaide Resources Ltd (ASX:ADN) will begin a drilling program in the first week of October, focused on the Baggy Green prospect at the company’s Eyre Peninsula gold project. The Eyre Peninsula gold project comprises eight tenements which cover 2,807 square kilometres in the Central Gawler Gold Province in South Australia. The program aims to build on the maiden 107,000 ounces gold mineral resource announced in July 2016 for the Barns deposit, located 5.
Upvote Downvote

 
Adelaide Resources Ltd secures $290,000 for Eyre Peninsula drilling

2016-08-16 proactiveinvestors.com.au
Adelaide Resources Ltd (ASX:ADN) is well positioned to advance its Eyre Peninsula projects following the award of two PACE discovery drilling grants of up to $290,000 by the South Australian Government. Significantly, changes made to the PACE scheme for 2016 increases both the maximum grant value and broaden the base of claimable items to include elements such as assays. The first grant is for up to $200,000 to test gold targets located in the vicinity of the Barns gold deposit where Adelaide recently announced a maiden resource of 107,000 ounces gold.
Upvote Downvote

 
Adelaide Resources Ltd to boost cash for gold and lithium exploration

2016-07-15 proactiveinvestors.com.au
Adelaide Resources Ltd (ASX:ADN) has interests in 16 exploration licenses, covering over 5,329 square kilometres, within South Australia, the Northern Territory and Queensland.
Upvote Downvote

 
Scoping study results boost Caravel shares

2016-06-28 businessnews.com.au
Caravel Minerals believes its Calingiri copper mine is set to be an outstanding project, based on a detailed scoping study that it believes is a best-case example of what listed companies need to prepare in order to meet current disclosure rules.
Upvote Downvote

 
Caravel jumps on scoping study results

2016-06-28 businessnews.com.au
Caravel Minerals believes its Calingiri copper mine is set to be an outstanding project, based on a detailed scoping study that it believes is a best-case example of what listed companies need to prepare in order to meet current disclosure rules.
Upvote Downvote

 
Adelaide Resources Ltd study firms up gold potential at Eyre Peninsula

2016-05-16 proactiveinvestors.com.au
Adelaide Resources Ltd (ASX:ADN) has interests in 16 exploration licenses, covering over 5,329 square kilometres, within South Australia, the Northern Territory and Queensland.
Upvote Downvote

 
Adelaide Resources Ltd to test salt lakes in South Australia for lithium

2016-04-27 proactiveinvestors.com.au
Adelaide Resources Ltd (ASX:ADN) has interests in 16 exploration licenses, covering over 5,329 square kilometres, within South Australia, the Northern Territory and Queensland.
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

11h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...